相关实验视频

Updated: Jan 14, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

重新定义骨髓瘤中的PET:使用FDG和醇PET/CT进行比较成像研究

Gursan Kaya^1,2, Serkan Akin³, Yahya Buyukasik⁴

¹Turkish Ministry of Health, Yozgat State Hospital, Dept. of Nuclear Medicine and Molecular Imaging, Yozgat, Türkiye. kayagursan@gmail.com.

European journal of nuclear medicine and molecular imaging

|October 23, 2025

概括

18F-胆-PET/CT (FCH) 在多发性骨髓瘤 (MM) 检测方面显示出比18F-FDG-PET/CT更高的精度. 在MM患者中,FCH PET/CT成像提供了更好的疾病评估.

科学领域:

核医学是一种核医学.
在瘤学瘤学.
放射性药物放射性药物放射性药物

背景情况:

18F-FDG-PET/CT在多发性骨髓瘤 (MM) 评估方面存在局限性,这是由于可变的六酶表达,可能导致假阴性结果.
18F-胆-PET/CT (FCH) 向膜脂合成,为MM成像提供了一个潜在的替代方案.

研究的目的:

为了比较18F-胆-PET/CT (FCH) 与18F-FDG-PET/CT用于多发性骨髓瘤 (MM) 检测的诊断性能.
评估FCH-PET/CT反映疾病负担的能力,并与MM患者的实验室标志物相关联.

主要方法:

一个单一中心的回顾性研究,涉及35名成年MM患者,他们在四周内接受了双追踪器PET/CT.
用Deauville标准 (IMPeTUs) 评分病变,并计算出探索性复合得分 (hTepe和myPET).
实验室标记物 (M蛋白,自由光链,骨髓透) 与成像同时收集.

主要成果:

在94.1%的敏感度和100%的PPV的患者中,FCH-PET/CT在91%的患者中发现了疾病,而FDG-PET/CT的检测率为49% (50.0%的敏感度,100%的PPV).
FCH表现出显著更高的超代谢焦点得分 (中位数为4对1;p<0.001) 并与大脑髓等离子体细胞透有适度的相关性.
FDG-PET/CT没有显示出一致的生化关联,而FCH吸收与血红蛋白和专蛋白相反相关.

结论:

在多发性骨髓瘤中,FCH-PET/CT表现出优于FDG-PET/CT的诊断性能,特别是在富含红髓的区域.
FCH-PET/CT更可靠地反映了MM疾病负担,并且更好地与实验室标记物保持一致.
FCH-PET/CT对常规MM分期,残留疾病评估和治疗反应评估具有潜在的实用性.

关键词:

胆胆是一种 F-18 FCH 聚乙烯/聚乙烯/聚乙烯在F-18 FDG PET/CT中使用.这就是Hexokinase的作用.多发性骨髓瘤是一种多发性骨髓瘤.血细胞失光症是一种血细胞失光症.

更多相关视频

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Functional Imaging of Brown Fat in Mice with 18F-FDG micro-PET/CT

Functional Imaging of Brown Fat in Mice with 18F-FDG micro-PET/CT

Published on: November 23, 2012

相关概念视频

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...